Literature DB >> 5097136

Differentiation of two genetically specific types of depression by the response to antidepressant drugs.

C M Pare, J W Mack.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5097136      PMCID： PMC1469184          DOI： 10.1136/jmg.8.3.306

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  6 in total

1.  [EFFECT OF ANTIDEPRESSIVES AND GENETIC FACTORS].

Authors:  J ANGST
Journal:  Arzneimittelforschung       Date:  1964-06

2.  Differentiation of two genetically specific types of depression by the response to anti-depressants.

Authors:  C M PARE; L REES; M J SAINSBURY
Journal:  Lancet       Date:  1962-12-29       Impact factor: 79.321

3.  A clinical analysis of the effects of tofranil in depression. Longitudinal and follow-up studies. Treatment of blood-relations.

Authors:  J ANGST
Journal:  Psychopharmacologia       Date:  1961-12-19

4.  Comparison of antidepressant drugs in depressive illnesses.

Authors:  P J DALLY; P ROHDE
Journal:  Lancet       Date:  1961-01-07       Impact factor: 79.321

5.  Drugs in the Treatment of Depression.

Authors:  W Sargant
Journal:  Br Med J       Date:  1961-01-28

6.  Intramuscular nialamide in depressed patients (a biochemical study).

Authors:  C M Pare; G C Jenner
Journal:  Dis Nerv Syst       Date:  1966-03
  6 in total
  11 in total

Review 1.  Neurochemistry and behavior in man.

Authors:  G S Omenn
Journal:  West J Med       Date:  1976-12

Review 2.  Genetics and psychopharmacology: prospects for individualized treatment.

Authors:  Charles U Nnadi; Joseph F Goldberg; Anil K Malhotra
Journal:  Essent Psychopharmacol       Date:  2005

Review 3.  Pharmacogenomic testing for neuropsychiatric drugs: current status of drug labeling, guidelines for using genetic information, and test options.

Authors:  Katarzyna Drozda; Daniel J Müller; Jeffrey R Bishop
Journal:  Pharmacotherapy       Date:  2014-02       Impact factor: 4.705

4.  Genetic features of antidepressant induced mania and hypo-mania in bipolar disorder.

Authors:  Alessandro Serretti; Paola Artioli; Raffaella Zanardi; Cristina Lorenzi; David Rossini; Cristina Cusin; Alessia Arnoldi; Marco Catalano
Journal:  Psychopharmacology (Berl)       Date:  2004-07-10       Impact factor: 4.530

5.  Brain amine concentrations after monoamine oxidase inhibitor administration.

Authors:  A B Jones; C M Pare; W J Nicholson; K Price; R S Stacey
Journal:  Br Med J       Date:  1972-01-01

6.  Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.

Authors:  S L Clark; D E Adkins; K Aberg; J M Hettema; J L McClay; R P Souza; E J C G van den Oord
Journal:  Psychol Med       Date:  2011-11-01       Impact factor: 7.723

7.  Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.

Authors:  D E Adkins; S L Clark; K Åberg; J M Hettema; J Bukszár; J L McClay; R P Souza; E J C G van den Oord
Journal:  Transl Psychiatry       Date:  2012-07-03       Impact factor: 6.222

8.  Convergent evidence from mouse and human studies suggests the involvement of zinc finger protein 326 gene in antidepressant treatment response.

Authors:  Ying-Jay Liou; Chien-Hsiun Chen; Chih-Ya Cheng; Shiow-Yi Chen; Tai-Jui Chen; Younger W-Y Yu; Fang-Shin Nian; Shih-Jen Tsai; Chen-Jee Hong
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

Review 9.  Pharmacogenetics of antidepressant response: an update.

Authors:  Antonio Drago; Diana De Ronchi; Alessandro Serretti
Journal:  Hum Genomics       Date:  2009-04       Impact factor: 4.639

10.  Candidate genes for antidepressant response to selective serotonin reuptake inhibitors.

Authors:  Francis E Lotrich; Bruce G Pollock
Journal:  Neuropsychiatr Dis Treat       Date:  2005-03       Impact factor: 2.570
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.